Firebrick Pharma Limited ( (AU:FRE) ) has issued an announcement.
Firebrick Pharma Limited has announced a proposed issue of 11,578,947 fully paid ordinary securities, with the issue date set for March 6, 2025. This move is part of a placement or other type of issue, potentially impacting the company’s market position by increasing its capital base and providing additional resources for its operations.
More about Firebrick Pharma Limited
Firebrick Pharma Limited operates in the pharmaceutical industry, focusing on the development and commercialization of innovative healthcare products.
YTD Price Performance: 45.16%
Average Trading Volume: 156,775
Technical Sentiment Consensus Rating: Sell
For a thorough assessment of FRE stock, go to TipRanks’ Stock Analysis page.